FDA to create new regulatory pathway for CBD products
The U.S. Food and Drug Administration (FDA) has announced it will be creating a new regulatory path for CBD products
The U.S. Food and Drug Administration (FDA) has announced it will be creating a new regulatory path for CBD products
SHARE-PRICE WARNING The Nasdaq stock exchange warns Organigram Holdings about their share price The Nasdaq stock exchange has warned Organigram
SOCIAL EQUITY PROGRAM The Parent Company announces details of the company’s Social Equity Ventures Brand Success Program Benzinga reports that
The restructuring initiative is expected to save the company USD$7 million by the end of 2023.
TO THE SENATE Minnesota House committee approves cannabis legalization bill Marijuana Moment reports that a third Minnesota House committee has
The medical cannabis company intends to rival other countries such as Canada, Germany and Israel with its own supply of medical cannabis from Scotland.
CANNABIS RESEARCH FDA issues clinical research guidance for cannabis Benzinga reports that The FDA has now issued final guidance outlining
This year’s The Grocer Awards 2022 included CBD by British Cannabisâ„¢ Dermal Patches as one of the New Products of The Year at their annual event, Hilton Bankside, London.Â
MAJORITY RULES Weed legalization supported by majority of U.S. voters According to a survey conducted by polling firm Data for
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.